February 2019

Dear Colleague,

Welcome to the first 2019 edition of Updates on Myeloproliferative Neoplasms (MPNs). We’re excited to share a new focus for our newsletter. In addition to bringing you the latest news in the field of MPNs, we’ll also be tackling the real-life challenges that you, the reader, encounter in your day-to-day practice.

Send in Your Questions!

In future editions, I’ll include a short video in which I address a question that you’ve submitted.

Have you been faced with a complicated clinical situation that you’d like some guidance on? Maybe you have a question regarding optimal management of your patients with MPNs? I’m all ears, so please send your questions to

Growing List of Resources

Also new this year, we’ll be creating an expanded Resource Center with helpful tools and guidelines to help guide your practice. And don’t forget about our existing MPN resources:

In the Literature

Last, but certainly not least, this month, we provide links to the latest news and literature in the field of MPNs, including research on the prevalence and severity of psychological distress in patients with MPNs, the addition of decitabine to ruxolitinib in the treatment of accelerated and blast-phase MPNs, and other topics.

Please feel free to share this newsletter and our enduring resources with your colleagues, and don’t hesitate to get in touch with me with comments or suggestions through the JADPRO editors at at any time.

Send in those questions!

Lindsey Lyle, MS, PA-C

Senior Instructor, Blood Cancers and Bone Marrow Transplant Program

University of Colorado, Anschutz Medical Campus


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.